
- Industry news
Industry news
- Category news
Category news
- Reports
- Key trends
- Multimedia
- Journal
- Events
- Suppliers
- Home
- Industry news
Industry news
- Category news
Category news
- Reports
- Key trends
- Multimedia
- Events
- Suppliers
Key takeaways
- TekniPlex Healthcare will showcase recyclable pharmaceutical packaging at The Pharma Days 2026.
- The company says the EU’s PPWR is driving demand for recyclable blister packaging and next-generation polymer solutions.
- TekniPlex Healthcare will highlight recyclable blister films and PFAS-free solutions.

TekniPlex Healthcare is showcasing its innovations for primary pharmaceutical packaging, advanced barrier materials, and expanded injection blow molding capacity for multidose vial applications.
TekniPlex Healthcare will present its solutions at the upcoming The Pharma Days 2026 (May 27–28), in Geneva, Switzerland.
Robin Van Landeghem, head of Strategic Innovation and Market Development at TekniPlex Healthcare, will give a presentation addressing how the EU’s Packaging and Packaging Waste Regulation (PPWR) is reshaping requirements for pharmaceutical packaging.
Van Landeghem says: “PPWR is accelerating a fundamental shift in how the pharmaceutical industry approaches primary packaging. Recyclability and material reduction are no longer aspirational. They are converging into the baseline expectation for blister formats.”
“TekniPlex Healthcare’s role is to give pharmaceutical companies the technical confidence and regulatory clarity to adopt next-generation polymer solutions without compromising on product protection or manufacturability.”

Key products
TekniPlex Healthcare will present recyclable solutions for applications requiring mid- to high-moisture barrier properties. The company offers Tekniflex COC thermoformable blister films, paired with barrier PP lidding films.
For drugs that require little to no moisture barrier, the company provides thermoformable polyester films and push-through polyester lidding films.
In partnership with Alpek Polyester, TekniPlex Healthcare has also launched a pharma-grade blister film containing 30% PCR content utilizing a mass balance approach, designed for applications with minimal barrier requirements.
TekniPlex Healthcare will also present its portfolio of advanced barrier solutions, including Aclar laminates and PFAS-free super barrier-coated solutions.
Last year, TekniPlex Healthcare began operations at its facility in Madison, US, as part of the company’s Barrier Protection Systems business.
Earlier, TekniPlex Healthcare increased injection blow molding capacity for multidose vial packaging, supporting different pharmaceutical liquid applications, including the ophthalmic segment.
Standard bottles range from 5–30 mL, including a 10 mL squeezable container developed for Aptar Pharma‘s Ophthalmic Squeeze Dispenser technology platform, which serves preservative-free multidose formulations in eye care.








